Pharming Group to participate in June investor conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pharming Group N.V. (Nasdaq: PHAR) has announced its management's participation in two key investor conferences in June 2025. The company will attend the Jefferies Global Healthcare Conference in New York on June 4-5, where CEO Fabrice Chouraqui will participate in a Fireside Chat Q&A session on June 5 at 2:00 pm EDT/20:00 CEST. Additionally, Pharming will participate in the Portzamparc Mid & Small Caps Conference in Paris on June 18.
Investors can access the Jefferies conference presentation via live webcast and replay through Pharming's website. Those interested in one-on-one meetings with management can arrange them through Pharming's IR team or their Jefferies or Portzamparc representatives.
Details
News Market Reaction – PHAR
On May 28, the day this news came out, PHAR closed 7.22% below the previous close.
Data tracked by StockTitan Argus for the May 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Leiden, the Netherlands, May 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June:
- Jefferies Global Healthcare Conference 2025, New York, USA, June 4-5, 2025
Fabrice Chouraqui, Chief Executive Officer, will participate in a Fireside Chat Q&A session on Thursday, June 5 at 2:00 pm EDT/20:00 CEST. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website. - Portzamparc (BNP Paribas) Mid & Small Caps Conference, Paris, France, June 18, 2025
For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Jefferies or Portzamparc representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.